|
发布时间：2011-04-12 - 点击：3次 - 字数：1700字 | Onset Medical Corporation announced today that the United States Patent Office has notified the Company a new patent has issued entitled Expandable Transluminal Sheath. This new patent provides 24 claims surrounding Onset's fundamental... |
|
发布时间：2011-04-09 - 点击：2次 - 字数：1042字 | Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market... |
|
发布时间：2011-04-08 - 点击：3次 - 字数：1312字 | On March 30, the Board of Appeal of the European Patent Office (EPO) in Munich decided to reject the appeal of B.Braun Melsungen AG ( B.Braun ) against the decision of the Opposition Division dated April 1, 2009. The March 30 judgement... |
|
发布时间：2011-04-07 - 点击：13次 - 字数：1663字 | Mirna Therapeutics, Inc. ( Mirna ) announced today that the United States Patent and Trademark Office has allowed patent claims related to the therapeutic application of the potent tumor suppressor microRNA, mir34a. The currently allowed... |
|
发布时间：2011-04-06 - 点击：4次 - 字数：1388字 | Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire LLC has filed a lawsuit in the U.S. District Court for the Southern District of New York against... |
|
发布时间：2011-04-05 - 点击：4次 - 字数：2338字 | Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has entered into a license agreement with Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. (the Teva... |
|
发布时间：2011-04-04 - 点击：3次 - 字数：5370字 | Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, today announced that it has strengthened its Board with the appointment of medical industry veteran, Bill... |
|
发布时间：2011-04-01 - 点击：9次 - 字数：2195字 | Asterand plc (LSE: ATD), a leading provider of human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, and its subsidiary BioSeek LLC today announced that the United States Patent and... |
|
发布时间：2011-03-30 - 点击：4次 - 字数：820字 | Zalicus Inc. (NASDAQ: ZLCS) announced today that it has been granted a composition-of-matter patent by the U.S. Patent and Trademark office covering its product candidate Synavive . United States patent number 7,915,265... |
|
发布时间：2011-03-30 - 点击：2次 - 字数：1113字 | Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX), a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled Methods of Improving the Pharmacokinetics of Doxepin.... |
|
发布时间：2011-03-29 - 点击：8次 - 字数：2154字 | Modular Genetics, Inc. (Modular) is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly.... |
|
发布时间：2011-03-28 - 点击：2次 - 字数：1484字 | Biotectix, LLC announced today the acquisition of all significant assets owned by Chameleon BioSurfaces Ltd. (Cambridge, United Kingdom). Financial terms were not disclosed. the Chameleon technology is highly complementary to the... |
|
发布时间：2011-03-28 - 点击：3次 - 字数：1042字 | Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading integrated global pharmaceutical company, today confirmed that it has received a favorable decision from the U.S. Court of Appeals for the Federal Circuit related to its ongoing... |
|
发布时间：2011-03-25 - 点击：2次 - 字数：758字 | Watson Pharmaceuticals, Inc. (NYSE: WPI), today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora (fentanyl buccal tablets C-II) infringes United States Patent... |
|
发布时间：2011-03-25 - 点击：3次 - 字数：483字 | AlphaRx Inc. (OTC BB:ALRX.OB) has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment. AlphaRx has... |
|
|